The Journal of Nutrition, Health & Aging© Volume 17, Number 4, 2013
BODY MASS INDEX, LIFESTYLES, PHYSICAL PERFORMANCE AND COGNITIVE DECLINE: THE "TREVISO LONGEVA (TRELONG)" STUDY
M. GALLUCCI1,9, S. MAZZUCO2, F. ONGARO2, E. DI GIORGI3, P. MECOCCI4, M. CESARI5, D. ALBANI6, G.L. FORLONI6, E. DURANTE7, G.B. GAJO7, A. ZANARDO8,9, M. SICULI8, L. CABERLOTTO8, C. REGINI9 1. Cognitive Impairment Centre, General Hospital of Treviso, Piazza Ospedale, 1, 31100 Treviso, Italy; 2. Department of Statistics University of Padova, Via Cesare Battisti, 241, 35121 Padova, Italy; 3. Territorial Health Services of Treviso, Via Isola di Mezzo, 37, 31100 Treviso, Italy; 4. Institute of Gerontology and Geriatrics, University Hospital, 06156 Perugia, Italy; 5. Institut du Vieillissement, Université de Toulouse, 37 Allées Jules Guesde, 31000 Toulouse, France; 6. Department of Neuroscience, “Mario Negri” Institute for Pharmacological Research, via La Masa, 19, 20156 Milan, Italy; 7. Transfusional Medicine Department, General Hospital of Treviso, Piazza Ospedale, 1, 31100 Treviso, Italy; 8. Clinical Pathology Department, General Hospital of Treviso, Piazza Ospedale, 1, 31100 Treviso, Italy; 9. FORGEI, Interdisciplinary Geriatric Research Foundation, Viale Trento Trieste, 19, 31100 Treviso, Italy. Corresponding author: Maurizio Gallucci, MD, Cognitive Impairment Centre, General Hospital of Treviso, Piazza Ospedale, 1, I-31100 Treviso, Italy, Email: [email protected]
Abstract: Objectives: The relative contributions of risk factors, as body mass index (BMI), depression, chronic diseases, smoking, and lifestyles (as physical and performance activity, social contacts and reading habit) to cognitive decline in the elderly are unclear. We explored these variables in relation to 7-year cognitive decline in long-lived Italian elderly. Design: Secondary data analysis of a longitudinal study of a representative, agestratified, population sample. Setting: The TREVISO LONGEVA (TRELONG) Study, in Treviso, Italy. Participants: 120 men and 189 women, age 77 years and older (mean age 80.2 ± 6.9 years) survivors after seven years of follow up. Measurements: Cognitive decline measured as difference between Mini-Mental State Examination (MMSE) score in 2003 and in 2010; Body mass index (BMI), handgrip, Short Physical Performance Battery (SPPB) score, social contacts, reading habit, sight, hearing, schooling, mediterranean diet and multiple clinical and survey data recorded at baseline in 2003. Results: In separate univariate analyses, age, SPPB score < 5, depressive symptoms (GDS) and more comorbidities (CCI) were associated with greater cognitive decline. Otherwise higher BMI, higher handgrip, reading habit, non-deteriorated sight and hearing, and schooling were protective. In a final multivariate model, age and higher BMI were associated with greater cognitive decline while reading habits was protective. SPPB score < 5 tends, though weakly, to be associated with greater cognitive decline. These associations remained with multivariate adjustment for gender, schooling, Charlson co-morbidity index (CCI) and baseline MMSE. Conclusion: Age and higher baseline BMI, independent of gender, and other confounding factors, are risk factors for cognitive decline. Reading habit plays a protective role seven years later among northern Italian adults aged 70 years or older. Low physical performance tends, though weakly, to be associated with greater cognitive decline. Key words: Cognitive decline, body mass index (BMI), physical performance, lifestyles.
Currently about twenty-four million people in the world have dementia and this amount will double every 20 years to 42 million by 2020 and to more than 80 million by 2040, assuming no changes in mortality, and no effective prevention strategies or curative treatments (1). According to the Global Burden of Disease estimates from the 2003 World Health Report, dementia contributed 11.2% of years lived with disability in people aged 60 years and older, more than stroke (9.5%), musculoskeletal disorders (8.9%), cardiovascular disease (5.0%) and all forms of cancer (2.4%) (2). In recent years, a growing body of evidence suggests that vascular risk factors and lifestyles may affect the risk of dementia in old age. Being overweight during midlife and late-life has been related to dementia (3-6). Differently some studies have not shown this relationship (7), or reported late-life decline in body mass index (BMI) prior to dementia onset (8-12). Differences in study designs and in lengths of observation periods contribute to make unclear the relationship between BMI and cognitive Received April 13, 2012 Accepted for publication July 19, 2012
status. Some studies provide evidence for the potential role of physical exercise in promoting cognitive health later in life (1316). We examined the change in cognitive status measured between baseline in 2003 and follow up in 2010 and its relationships with baseline measures of BMI, lifestyles, physical functioning and other factors in the “TREVISO LONGEVA” (TRELONG) Study, a prospective cohort study of women and men, aged 70 years and older in Northern Italy. The TRELONG Study was realized to study the human aging in an area, such as Treviso, where the highest longevity in Italy, especially among women, is observed (17). Methods
The TRELONG Study, was initiated in 2003. Eligible participants lived in the municipality of Treviso in Northeast Italy. At the beginning of this study in 2003 Treviso had a resident population of 81,700, of whom 13,861 (17%) were over the age of 70 years. Participants were systematically sampled from the list of residents of the Registry Office of
The Journal of Nutrition, Health & Aging© Volume 17, Number 4, 2013
JNHA: CLINICAL NEUROSCIENCES
Treviso, based on an initial plan to include 100 participants per sex and 10 year age group, with 125 women and 125 men aged 70-79 years and all of those over 100 years be included. Thus 670 adults were eligible. Of these, 668 participated (99.7% response rate), 311 men and 357 women, aged 70 years and older (mean age 84 ± 8 years, range 70-105.5 years). An interviewer-administered questionnaire and a blood sample were collected at participants’ homes (18). Information on cognitive performances was also obtained from caregivers. Baseline characteristics of this study population and methodological details have been published previously, and form the basis of these analyses (18). The study protocol was approved by the Ethical Committee of the National Institute on Research and Care of the Elderly (INRCA, Italy). All participants and/or their caregivers provided written consent. A follow up interviewer-administered questionnaire and a blood sample were collected at home from the 309 survivor participants in March 2010. The only follow-up data used in the current study is the change of MMSE score between 2003 and 2010. In Table 1 the main baseline (2003) data of 309 survivors at follow up in 2010 are reported. Global cognition measure Global cognition was measured using the 30-point mini mental state examination (MMSE) (19) at baseline in 2003 and at 2010 follow up. Raw scores were corrected for age and education (20).
Anthropometric Measures Body weight and body height were measured (18). Body mass Index (BMI) was calculated as kg/m2.
Physical performance measures The Short Physical Performance Battery (SPPB) was used to measure standing balance, walking, and chair stand tests. Standing balance tests included tandem, semitandem and sideby-side stands. To test walking speed, each participant was timed for two walks on an 8-foot walking course. The faster of the two walks was used. The chair stand test assesses the ability to rise from a chair five times as quickly as possible. Performance categories were created for each set of performance measures to permit analyses that included those unable to perform a task, using criteria already established and used in the literature (21-22). A summary performance scale was created by adding up the category scores for walking, chair stand and balance tests (21). Physical strength was measured via handgrip using a Collins dynamometer (Witte GMBH Chirurgische Instrumente, Adult Size, 12.7 x 5.7 cm, Solingen, Germany) and taking the average of three assessments with the stronger hand (18, 22). Biochemical Measures A fasting morning blood sample was collected at home from each participant and transported to the Clinical Chemistry
Laboratory of Treviso Hospital, within 30 minutes. Routine hematological and clinical chemistry tests were performed immediately using standard laboratory methods. Serum biochemical markers, such as albumin, were determined by commercial methods (Roche Diagnostics GMBH, D-68298 Mannheim Germany) on a Modular Analyzer (18).
Assessment of chronic disease In-person interviews and examination of medical records provided information on history of chronic diseases as cerebrovascular disease, chronic renal insufficiency, tumors and others (18, 22). Using this information, a Charlson comorbidity index (CCI) was determined (23-27). The CCI contains 19 categories of pathologies, which were defined using ICD-9-CM (2). The categories are: acute myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic obstructive pulmonary disease, connective tissue disease, gastric ulcer, mild liver insufficiency, diabetes, hemiplegia, moderate-tosevere renal insufficiency, diabetes with end organ damage, solid tumors, leukemia, lymphomas, medium-to-severe liver insufficiency, tumor metastases, acquired immune deficiency syndrome (AIDS), and age. Each category is weighed according to the adjusted risk of 1-year mortality. The overall co-morbidity score is related to the likelihood of mortality within one year; the higher the score, the more severe the comorbidity burden (23). Depressive symptoms were assessed using the geriatric depression scale (GDS) (28, 29). Sight and hearing were also considered. The sight was classified as: (a) normal, (b) slightly impaired, (c) greatly impaired, and (d) blind, asking the subjects and showing them colored tables. Hearing was determined to be: (a) normal, (b) slightly impaired, (c) greatly impaired, and (d) total deafness. The interviewer pronounced the sentence ‘‘Today is a sunny/rainy day’’ slowly and softly from a 4 meters distance. In the analyses presented in this paper, we considered sight and hearing categories (a) versus (bd) (18, 22). Lifestyles measures Lifestyle measures included physical activity, socialization, reading, and smoking. To assess physical activity, participants were asked whether they took walks and/or did gardening every day. In the current study, we considered physical activity categories “at least one activity” versus “none”. Socialization was assessed via: (a) regular visits to friends, (b) participation in recreation and social centres, (c) involvement in socially useful activities, or (d) volunteer work. Cultural activities included regular reading activity (18, 30). Each participant reported if he smoked. Number of years of education was recorded. Dietary patterns were also assessed, particularly intake of the Mediterranean diet: cereals, fish, vegetables and fruit (31-33). It was asked if the cereals were usually eaten at least once a day, vegetables and fruit at least twice a day, and
The Journal of Nutrition, Health & Aging© Volume 17, Number 4, 2013
fish at least twice a week.
THE "TREVISO LONGEVA (TRELONG)" STUDY
Participants were initially characterized on a variety of clinical and surveyed variables. Medians and interquartile ranges, percentiles and percentages were calculated. Moreover an univariate linear regression on each covariate that was taken into account was calculated. The multivariate statistical analysis consists of a logistic regression on the dichotomic variable taking the value 1 if the individual underwent between 2003 and 2010 a MMSE decline greater than its standard deviation (5.9) and zero otherwise. Information on MMSE decline was available only for participants who survived up to 2010, thus individuals who died before 2010 have been disregarded. No data were inputted and missing data were removed. Participants were stratified on the basis of SPPB score (8 years vs. ≤8 years), albumin ( 8 ys BMI*Age
Confidence interval Coefficient Std. Error 2.5% 97.5% Wald x 2 statistic 0.064 0.476 -0.063 1.049 0.678 -0.902 -0.071 -0.605 -0.014
0.056 0.152 0.338 0.480 0.409 0.449 0.110 0.376 0.006
-0.044 0.182 -0.733 0.104 -0.132 -1.783 -0.292 -1.371 -0.026
0.176 0.781 0.600 1.998 1.479 -0.012 0.143 0.111 -0.002
1.341 9.828 0.035 4.779 2.749 4.028 0.416 2.595 5.410
p-value 0.247 0.002 0.852 0.029 0.097 0.045 0.519 0.107 0.020
** * . * *
A positive effect indicates that the independent variable is considered a risk factor (increased cognitive impairment) and a negative effect indicates that the variable is a protective factor. Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
MMSE=Mini Mental State Examination; BMI= Body Mass Index; SPPB=Short Physical Performance Battery; CCI=Charlson Co-morbidity Index
In the multivariate model, the BMI was a risk factor as it was directly related to the extent of cognitive impairment while the reading habit appeared as protective; age maintained a positive correlation with cognitive impairment. Physical impairment (SPPB score < 5) tended, though weakly, to play as risk factor for cognitive decline. The effects of BMI should be also read along with the interaction that this variable had with age. The interaction of BMI with age was significant and negative. This means that the positive effect of the BMI decreased as the age of the individual increased.
In the current study age is a risk factor for cognitive impairment, according to what is already known and reported (35-44). In fact, aging is generally accompanied by modification of the cognitive profile (35). Many older people may experience difficulties in various cognitive domains such as memory (36), attention (37), executive functions (38, 39), and processing speed (40) and consequently, a loss of autonomy in activities of daily living (41-43). There have been several prospective or nested epidemiologic reports (3-6, 8, 10, 11, 45-48) evaluating BMI in relationship to dementia. Most (3-6, 45, 46, 48) have shown a high BMI to be a risk factor for dementia when measured at least a decade prior to cognitive decline onset. Other longitudinal studies describe that a high BMI has a protective effect when measured within five years before the onset of dementia: Luchsinger at al. showed that dementia risk decreased with increasing BMI in older people over 76 years (49) and Buchman at al. reported that declining body mass index is associated with increased risk of incident Alzheimer disease (AD) (50). Many cross-sectional reports underlined that low BMI or underweight are related to dementia (51-55). In our analysis higher BMI score is a risk factor for the occurrence of cognitive decline over seven years. This relationship remained after potential confounders were considered. These findings demonstrate that the relationship between overweight and cognition is complex, dynamic and a function of time. Obesity accompanies and even promotes survival (5658), but then becomes a risk factor for dementia among those who are susceptible due to survivorship to high age (59). The interplay of adiposity and the brain occurring over the course of the lifespan is complex and in relationship to developmental origins, midlife comorbidities, disruptions in brain structure and cognition (59, 60). The association between obesity and dementia is suggested by the central role of obesity in the development of hypertension, dyslipidemia, diabetes and metabolic syndrome. In the Honolulu-Asia Aging Study a higher cardiovascular risk factor burden in middle age increased the risk of vascular dementia 25 years later (61). Brain atrophy, an early marker of cognitive decline, is a manifestation of neuronal degeneration (62, 63) and has been related, using computed tomography (CT), to higher BMI levels 24 years before (64). Elevated BMI is associated with reduced global brain volumes, in a cross-sectional study of women and men aged 40–66 years (65). A number of studies demonstrate that persons with AD have lower weight and BMI (54, 66-69) and lose body mass (70, 71). This may result from a variety of factors including changes in eating habits and access to adequate nutrition due to memory impairment (72-74), changes in taste and smell, solitude and depression. Evidences in literature suggest that involuntary weight loss (IWL) is more a consequence than a cause of dementia, in particular of AD, but chronic diseases and disability, inadequately treated from
The Journal of Nutrition, Health & Aging© Volume 17, Number 4, 2013
THE "TREVISO LONGEVA (TRELONG)" STUDY
the nutritional standpoint, may also worsen and accelerate cognitive impairment (75). Obesity and high BMI values dynamically play the role of long-term risk factors and protective factors in the short-term, when the degenerative or vascular brain lesions cause cognitive decline and also induce loss of memory and appetite, apathy, disinterest, depression and thus weight loss. Being overweight is a risk factor for cardiovascular disease in adults, along with hypertension, metabolic syndrome and diabetes. In people who survive beyond 70 years of age, overweight plays a protective role with respect to mortality, but contributes to the onset of cognitive impairment. As we know, there are not many studies that have evaluated the effect of the habit of reading in older people towards the changes in the cognitive profile. Uchida et al. introduced a new cognitive intervention program for normal aged people, and demonstrated that daily training program involving reading and arithmetic problems was effective for the improvement of cognitive functions of community-dwelling elderly (76). Nouchi et al. used simple training tasks (reading aloud and simple calculation) to reveal the beneficial effects of learning therapy on a wide range of cognitive functions in elderly people (77). Jefferson et al. showed cross-sectional findings suggesting that education and reading ability are the most-robust proxy measures of cognitive reserve in relation to late-life cognition (78). Our previous cross-sectional work showed that reading habit is associated with better cognitive performance; this correlation remained significant after adjusting for confounding factors, such as comorbidity and hearing function (30). In the current study reading habit shows itself as a protective factor against cognitive decline, confirming the correlation highlighted in our previous cross-sectional work (30). Public health programs that promote the diffusion of habit to read, even in old age, could reduce the incidence of cognitive impairment. The ability to maintain independence and quality of life in older people depends significantly on the maintenance of cognitive and physical performance but the association between cognitive and physical performance and their rate of change with age is unclear. Some evidences indicate that motor and cognitive systems are both likely to be influenced by processes, both developmental and degenerative, which regulate CNS function; the suggestion that there are developmental and ageing processes which influence both cognitive and physical performance has been termed the “common cause” hypothesis (79, 80). According to this hypothesis is the evidence that both cognitive and physical performance can be negatively influenced in parallel by factors such as chronic disease, sedentary lifestyles and poor socioeconomic conditions (81-85). Atkinson et al. found that baseline global cognitive function and global cognitive decline independently predicted declines in specific physical measures but that none of their physical measures predicted cognitive change; these findings support their hypothesis that cognitive function decrements in older
adults on average precede or co-occur with physical performance declines (86). On the contrary many studies have demonstrated that baseline physical performance predicts declines in cognitive function and/or incident cognitive impairment or dementia (13-16, 87-98). The current study is in line with these findings, in fact good physical performance aims to show itself, though weakly, as a protective factor against cognitive decline. In particular the SPPB, as well as being a predictor of the degree of functional autonomy and disability (99), might be a marker of cognitive status. Conclusions
Age affects the extent of cognitive decline after seven years. A high BMI, at advanced age, may play a protective role regarding the mortality, but is a risk factor for cognitive decline. The reading habit shows itself as a protective factor against cognitive decline. Good physical performance aims to show itself, though weakly, as a protective factor against cognitive decline. This study has some limitations. Firsty, the magnitude of the decline occurred in the population observed from 2003 to 2010 is contained in 2.86 points of MMSE score. It is possible that a greater decline would have allowed the identification of greater linkages between potential risk factors and loss of cognition. Such a low cognitive decline is possibly due also to a re-test effect: it has been showed that people who are asked to compile any cognitive test have a better performance if the same test is submitted even long after the first one (100, 101). In addition, the MMSE test could have been submitted to respondents also in other settings not depending on the survey in the years between cross-sectional and follow up. Secondly, the sample size is limited and this makes the statistical tests less powerful. The third limitation is that some risk factors for cognitive decline, as diabetes (102) and hypertension (103), are not statistically significant in our analysis. Perhaps this is again due to the low sample size. However, there are also several strengths. Firstly, this is a systematic sample of adults aged 70 years and older from one of the longest lived communities in Italy and the sample is highly representative of the community. Secondly, the sample observed is residing at home and was drawn at random from the list of residents of the municipality of Treviso: the study sample is therefore representative of the real world. In fact many studies are being conducted in selected samples: patients, only men or only women, etc. The third strength is that the study sample was well characterized by a large amount of data that was in part set out in previous published works (18, 22, 30). Furthermore measurement of cognitive impairment using the MMSE score represents a simple and homogeneous tool; often the diagnosis of dementia is underestimated and does not take into account the presence of mild cognitive impairment. Finally, some studies involving cognition and BMI do not consider physical performance; we have also considered this
The Journal of Nutrition, Health & Aging© Volume 17, Number 4, 2013
JNHA: CLINICAL NEUROSCIENCES
parameter among the potential factors related to cognitive impairment. Additional years of observation will further confirm these findings. Acknowledgements: This study was supported by grants from the Veneto Region, the Treviso Municipality, Treviso Province and Veneto Banca Foundation. We are grateful to all people who kindly agreed to participate in this study and to Giuliana Santamaria for manuscript editing. Conflict of interest statement: None.
‘No Disclosures to Report’
14. 15. 16.
22. 23. 24.
25. 26. 27.
Ferri CP, Prince M, Brayne C, Brodaty H et al., Global prevalence of dementia: a Delphi consensus study. Lancet 2005 dec 17;366(9503):2112-7 World Health Organization. World Health Report 2003 – Shaping the future. Geneva: WHO, 2003. Gustafson DR, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow up of overweight and risk for Alzheimer’s disease. Arch Intern Med 2003;163:1524 –1528. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005;62:1556 –1560. Rosengren A, Skoog I, Gustafson D, Wilhelmsen L. Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med 2005;165:321–326. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Jr., Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005;330:1360 –1364. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R. Measures of adiposity and dementia risk in elderly persons. Arch Neurol 2007;64:392–398. Stewart R, Masaki K, Xue QL, et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 2005;62:55–60. Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L. Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc 2008;56:111–116. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc 1996;44:1147–1152. Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA. Change in body mass index and risk of incident Alzheimer disease. Neurology 2005;65:892– 897. Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 2009;66:336 –342. Alfaro-Acha A, Al Snih S, Raji MA, Kuo YF, Markides KS, Ottenbacher KJ. Handgrip strength and cognitive decline in older Mexi¬can Americans. J Gerontol A Biol Sci Med Sci. 2006;61(8):859–865. Alfaro-Acha A, Al Snih S, Raji MA, Markides KS, Ottenbacher KJ. Does 8-foot walk time predict cognitive decline in older Mexicans Americans? J Am Geriatr Soc. 2007;55(2):245–251. Inzitari M, Newman AB, Yaffe K, et al. Gait speed predicts decline in attention and psychomotor speed in older Adults: The Health Aging and Body Composition Study. Neuroepidemiology. 2007;29(3-4):156–162. Wang L, Larson EB, Bowen JD, van Belle G. Performance-based physical function and future dementia in older people. Arch Intern Med. 2006;166(10):1115–1120. Marsili M,Marsiglia D: Tavole di mortalità della popolazione italiana per provincia e regione di residenza. Anno 1998, Roma, Servizio Popolazione Istruzione e Cultura, 2001 Gallucci M, Ongaro F, Bresolin F, et al. The Treviso Longeva (Trelong) study: a biomedical, demographic, economic and social investigation on people 70 years and over in a typical town of North-East of Italy. Arch Gerontol Geriatr 2007;44 Suppl 1:173-92. Folstein MF, Folstein SE,McHugh PR: "Mini-Mental State" A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975; 12:189-198 Magni E, Binetti G, Bianchetti A, et al: Mini-mental state examination: a normative study in Italian elderly population. Eur J Neurol 1996; 3:1-5 Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB, 1994. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J. Gerontol. Biol. Sci. Med. Sci. 49, M85–M94. Gallucci M, Ongaro F, Meggiolaro S et al., Factors related to disability: Evidence from the ‘‘Treviso Longeva (TRELONG) Study’’, Archives of Gerontology and Geriatrics 52 (2011) 309–316 Charlson, M.E., Pompei, P., Ales, K.L., McKenzie, C.R., 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chron. Dis. 40, 373–383. Cleves, M.A., Sanchez, N., Draheim, M., 1997. Evaluation of two competing methods for
45. 46. 47. 48. 49.
calculating Charlson’s comorbidity index when analyzing short-term mortality using administrative data. J. Clin. Epidemiol. 50, 903–908. Singh, B., Bhaya, M., Stern, J., Roland, J.T., Zimbler, M., Rosenfeld, R.M., Har-El, G., Lucente, F.E., 1997. Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 107, 1469–1475. Zhang, J.X., Iwashyna, T.J., Christakis, N.A., 1999. The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in Medicare claims. Med. Care 37, 1128–1139. Schneeweiss, S., Maclure, M., 2000. Use of comorbidity scores for control of confounding in studies using administrative databases. Int. J. Epidemiol. 29, 891–898. Yesavage, J.A., Brink, T.L., Rose, T.L., Lum, O., Huang, V., Adey, M., Leirer, V.O., 1983. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. 17, 37–49. Montorio, I., Izal, M., 1996. The Geriatric Depression Scale: a review of its development and utility. Int. Psychogeriatr. 8, 103–112. Gallucci, M., Antuono, P., Ongaro, F., Forloni, P.L., Albani, D., Amici, G.P., Regini, C., 2009. Physical activity, socialization and reading in the elderly over the age of seventy: What is the relation with cognitive decline? Evidence from ‘‘The Treviso Longeva (TRELONG) study’’ Arch. Gerontol. Geriatr. 48, 284–286. Rees, S., Harborne, J., 1984. Flavonoids and other phenolics of Cichorium and related members of the Lactueaceae (Compositae). Bot. J. Linn. Soc. 89, 313–319. Papetti, A., Daglia, M., Gazzani, G., 2002. Anti- and pro-oxidant activity of watersoluble compounds in Cichorium intybus var. Silvestre (Treviso red chicory). J. Pharmaceut. Biomed. Anal. 30, 939–945. Buckland, G., Bach, A., Serra-Majem, L., 2008. Obesity and the Mediterranean diet: a systematic review of observational and intervention studies. Obes. Rev. 9, 582–593. R Development Core Team (2012). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-070, URL http://www.R-project.org/. Hedden T, Gabrieli JD: Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 2004, 5:87-96. Salthouse TA: Memory aging from 18 to 80. Alzheimer Dis Assoc Disord 2003, 17:162167. Yakhno NN, Zakharov VV, Lokshina AB: Impairment of memory and attention in the elderly. Neurosci Behav Physiol 2007, 37:203-208. Royall DR, Palmer R, Chiodo LK, Polk MJ: Declining executive control in normal aging predicts change in functional status: The Freedom House Study. J Am Geriatr Soc 2004, 52:346-352. Coppin AK, Shumway-Cook A, Saczynski JS, Patel KV, Ble A, Ferrucci L, Guralnik JM: Association of executive function and performance of dualtask physical tests among older adults: analyses from the InChianti study. Age Ageing 2006, 35:619-624. Salthouse TA: The processing-speed theory of adult age differences in cognition. Psychol Rev 1996, 103:403-428. Cahn-Weiner DA, Malloy PF, Boyle PA, Marran M, Salloway S: Prediction of functional status from neuropsychological tests in community-dwelling elderly individuals. Clin Neuropsychol 2000, 14:187-195. Lee Y, Kim JH, Lee KJ, Han G, Kim JL: Association of cognitive status with functional limitation and disability in older adults. Aging Clin Exp Res 2005, 17:20-28. Owsley C, McGwin G Jr: Association between visual attention and mobility in older adults. J Am Geriatr Soc 2004, 52:1901-1906. Katz MJ, Lipton RB, Hall CB, Zimmerman ME, Sanders AE, Verghese J, Dickson DW, Derby CA. Age-specific and Sex-specific Prevalence and Incidence of Mild Cognitive Impairment, Dementia, and Alzheimer Dementia in Blacks and Whites: A Report From the Einstein Aging Study. Alzheimer Dis Assoc Disord. 2011 Dec 7. Whitmer, R.A., Gunderson, E.P., Quesenberry Jr., C.P., Zhou, J., Yaffe, K., 2007. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr. Alzheimer Res. 4, 103–109. Hayden, K., Zandi, P., Lyketsos, C., Khachaturian, A., Bastian, L., Charoonruk, G., Tschanz, J., Norton, M., Pieper, C., Munger, R., Breitner, J., Welsh-Bohmer, K., Cache County Investigators, 2006. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis. Assoc. Disord. 20, 93–100. Nourhashemi F, Deschamps V, Larrieu S, Letenneur L, Dartigues JF, Barberger-Gateau P. Body mass index and incidence of dementia: the PAQUID study. Neurology 2003;60:117–119. Chiang, C.J., Yip, P.K.,Wu, S.C., Lu, C.S., Liou, C.W., Liu, H.C., Liu, C.K., Chu, C.H., Hwang, C.S., Sung, S.F., Hsu, Y.D., Chen, C.C., Liu, S.I., Yan, S.H., Fong, C.S., Chang, S.F., You, S.L., Chen, C.J., 2007. Midlife risk factors for subtypes of dementia: a nested case-control study in Taiwan. Am. J. Geriatr. Psychiatry 15, 762–771. Luchsinger, J.A., Patel, B., Tang, M.X., Schupf, N., Mayeux, R., 2007. Measures of adiposity and dementia risk in elderly persons. Arch. Neurol. 64, 392–398. Buchman, A.S., Wilson, R.S., Bienias, J.L., Shah, R.C., Evans, D.A., Bennett, D.A., 2005. Change in body mass index and risk of incident Alzheimer disease. Neurology 65, 892–897. Faxen-Irving, G., Basun, H., Cederholm, T., 2005. Nutritional and cognitive relationships and longterm mortality in patients with various dementia disorders. Age Ageing 34, 136–141. Hogan, D.B., Ebly, E.M., Rockwood, K., 1997. Weight, blood pressure, osmolarity, and
The Journal of Nutrition, Health & Aging© Volume 17, Number 4, 2013
62. 63. 64.
68. 69. 70.
74. 75. 76. 77.
THE "TREVISO LONGEVA (TRELONG)" STUDY
glucose levels across various stages of Alzheimer's disease and vascular dementia. Dement. Geriatr. Cogn. Disord. 8, 147–151. Knopman, D.S., Edland, S.D., Cha, R.H., Petersen, R.C., Rocca, W.A., 2007. Incident dementia in women is preceded by weight loss by at least a decade. Neurology 69, 739–746. White, H., Pieper, C., Schmader, K., Fillenbaum, G., 1996. Weight change in Alzheimer's disease. J. Am. Geriatr. Soc. 44, 265–272. White, H., Pieper, C., Schmader, K., 1998. The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J. Am. Geriatr. Soc. 46, 1223–1227. Dey DK, Rothenberg E, Sundh V, et al: Height and body weight in the elderly. I. A 25year longitudinal study of a population aged 70 to 95 years. Eur J Clin Nutr 1999; 53:905914 Flicker L, McCaul KA, Hankey GJ, et al: Body mass index and survival in men and women aged 70 to 75. J Am Geriatr Soc 2010; 58:234-241 Gustafson, D., Mazzuco, S., Gallucci, M., et al.: Body mass index, cognition, disability, APOE genotype and mortality: the “TREVISO LONGEVA (TRELONG)” Study. Am J Geriatr Psychiatry, 2011 Oct 8 Gustafson, D.: A life course of adiposity and dementia. Eur J Pharmacol 2008; 585:163175 Ross, M.G., Desai, M., Khorram, O., McKnight, R.A., Lane, R.H., Torday, J., 2007. Gestational programming of offspring obesity: a potential contributor to Alzheimer's disease. Curr. Alzheimer Res. 4, 213–217. Kalmijn S, Foley D, White L, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men: the Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol. 2000;20:2255-2260. deLeon, M.J., George, A.E., Golomb, J., Tarshish, C., Convit, A., Kluger, A.,Santi, S., McRae, T., Ferris, S.H., Reisberg, B., Ince, C., Rusinek, H., Bobinski, M., Quinn, B., Miller, D.C., Wisniewski, H.M., 1996. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol. Aging 18, 1–11. Visser, P.J., Verhey, F.R.J., Hofman, P.A.M., Scheltens, P., Jolles, J., 2002. Medial temporal lobe atrophy predicts Alzheimer' disease in patients with minor cognitive impairment. J. Neurol. Neurosur. Psychiatr. 72, 491–497. Gustafson, D., Lissner, L., Bengtsson, C., Björkelund, C., Skoog, I., 2004. A 24-year follow-up of body mass index and cerebral atrophy. Neurology 63, 1876–1881. Ward, M.A., Carlsson, C.M., Trivedi, M.A., Sager, M.A., Johnson, S.C., 2005. The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study. BMC Neurol. 5, 23–29. Wolf-Klein GP, Silverstone FA. Weight loss in Alzheimer’s disease: an international review of the literature. Int Psychogeriatr 1994;6:135–142. Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet 2001;357:354–357. Shatenstein B, Kergoat MJ, Nadon S. Weight change, nutritional risk and its determinants among cognitively intact and demented elderly Canadians. Can J Public Health 2001;92:143–149. Payette H, Kergoat MJ, Shatenstein B, Boutier V, Nadon S. Validity of self-reported height and weight estimates in cognitively-intact and impaired elderly individuals. J Nutr Health Aging 2000;4:223–228. Cronin-Stubbs D, Beckett LA, Scherr PA, et al. Weight loss in people with Alzheimer’s disease: a prospective population based analysis. Br Med J 1997;314:178–179. White H, Pieper C, Schmader K, Fillenbaum G. A longitudinal analysis of weight change in Alzheimer’s disease. J Am Geriatr Soc 1997;45:531–532. Salvà A, Andrieu S, Fernandez E, Schiffrin EJ, Moulin J, Decarli B, Rojano-i-Luque X, Guigoz Y, Vellas B; NutriAlz group. Health and nutrition promotion program for patients with dementia (NutriAlz): cluster randomized trial. J Nutr Health Aging. 2011;15(10):82230. Gillette Guyonnet S, Abellan Van Kan G, Alix E, Andrieu S, Belmin J, Berrut G, Bonnefoy M, Brocker P, Constans T, Ferry M, Ghisolfi-Marque A, Girard L, Gonthier R, Guerin O, Hervy MP, Jouanny P, Laurain MC, Lechowski L, Nourhashemi F, RaynaudSimon A, Ritz P, Roche J, Rolland Y, Salva T, Vellas B; International Academy on Nutrition and Aging Expert Group. IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. J Nutr Health Aging. 2007 Jan-Feb;11(1):38-48. Andrieu S, Reynish W, Nourhashemi F et al. Nutritional risk factors for institutional placement in Alzheimer's disease after one year follow-up. J Nutr Health Aging 2001; 5: 113-7 Inelmen EM, Sergi G, Coin A, Girardi A and Manzato E. An open-ended question: Alzheimer’s disease and involuntary weight loss: which comes first? Aging Clin Exp Res, 2010, Vol. 22, No 3, 192-197. Uchida S, Kawashima R: Reading and solving arithmetic problems improves cognitive functions of normal aged people: a randomized controlled study. Age (Dordr) 2008, 30:2129. Nouchi R, Taki Y, Takeuchi H, et al. Beneficial effects of reading aloud and solvingsimple arithmetic calculations (learning therapy) on a wide range of cognitive functions in the healthy elderly: study protocol for a randomized controlled trial. Trials 2012, 13:32
81. 82. 83. 84.
99. 100. 101.
Jefferson AL, Gibbons LE, Rentz DM, Carvalho JO, Manly J, Bennett DA and Jones R N (2011), A Life Course Model of Cognitive Activities, Socioeconomic Status, Education, Reading Ability, and Cognition. Journal of the American Geriatrics Society, 59: 1403–1411. Lindenberger U, Baltes P. Sensory functioning and intelligence in old age: a strong connection. Psychol Aging 1994;9:339–55. Christensen H, Mackinnon AJ, Korten A, Jorm AF. The “Common Cause Hypothesis” of cognitive aging: evidence for not only a common factor but also specific associations of age with vision and grip strength in a cross-sectional analysis. Psychol Aging 2001;16:588–99. Anstey KJ, Smith GA. Interrelationships among biological markers of aging, health, activity, acculturation and cognitive performance in late adulthood. Psychol Aging 1999;14:605–18. Guralnik JM, Ferrucci L, Penninx BWJH, Kasper JD, Leveille SG, Bandeen-Roche K, Fried LP. New and worsening conditions and change in physical and cognitive peformance during weekly evaluations over 6 months: The Women’s Health and Aging Study. J Gerontol 1999;54A:M410–M422. Kuh D, Bassey EJ, Butterworth S, Hardy R, Wadsworth MEJ. on behalf of the Musculoskeletal study team. Grip strength, postural control, and functional leg power in a representative cohort of British men and women; associations with physical activity, health status, and socioeconomic conditions. J Gerontol Med Sci 2005;60A:224–31. Richards M. Cognitive links across the lifecourse and implications for health in later life. Age Ageing 2003;29:477–8. Richards M, Sacker A. Lifetime antecedents of cognitive reserve. J Clin Exp Neuropsychol 2003;25:614–24. Atkinson HH, Rapp SR, Williamson JD, Lovato J, Absher JR, Gass M, Henderson VW, Johnson KC, Kostis JB, Sink KM, Mouton CP, Ockene JK, Stefanick ML, Lane DS, Espeland MA. The relationship between cognitive function and physical performance in older women: results from the women's health initiative memory study. J Gerontol A Biol Sci Med Sci. 2010 Mar;65(3):300-6. Epub 2009 Sep 29. Angevaren M, Aufdemkampe G, Verhaar HJ, Aleman A, Vanhees L. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005381. Teri L, Logsdon RG, McCurry SM. Exercise interventions for dementia and cognitive impairment: the Seattle Protocols. J Nutr Health Aging. 2008 Jun-Jul;12(6):391-4. Geda YE, Roberts RO, Knopman DS et al., Physical exercise, aging, and mild cognitive impairment: a population-based study. Arch Neurol. 2010 Jan;67(1):80-6. Liu-Ambrose T, Eng JJ, Boyd LA, Jacova C, Davis JC, Bryan S, Lee P, Brasher P, Hsiung GY. Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment. BMC Neurol. 2010 Feb 17;10:14. Schneider BC, Lichtenberg PA. Executive ability and physical performance in urban Black older adults. Archives of Clinical Neuropsychology 23 (2008) 593–601 Verghese J, Wang C, Lipton RB, Holtzer R, Xue X. Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neu¬rosurg Psychiatry. 2007;78(9):929–935. Buchman AS, Wilson RS, Boyle PA, Bienias JL, Bennett DA. Grip strength and the risk of incident Alzheimer’s disease. Neuroepidemiol¬ogy. 2007;29(1–2):66–73. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ, Buschke H. Abnormality of gait as a predictor of non-Alzheimer’s dementia. N Engl J Med. 200228;347(22):1761–1768. Marquis S, Moore MM, Howieson DB, et al. Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol. 2002;59(4):601–606. Louis ED, Tang MX, Mayeux R. Parkinsonian signs in older people in a community-based study: risk of incident dementia. Arch Neurol. 2004;61(8):1273–1276. Waite LM, Grayson DA, Piguet O, Creasey H, Bennett HP, Broe GA. Gait slowing as a predictor of incident dementia: 6-year longitudinal data from the Sydney Older Persons Study. J Neurol Sci. 2005;229–230:89 Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, Cesari M, Donini LM, Gillette Guyonnet S, Inzitari M, Nourhashemi F, Onder G, Ritz P, Salva A, Visser M, Vellas B. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging. 2009 Dec;13(10):881-9. Guralnik, J M, Ferrucci, L, Simonsick, E M, Salive, M E, & Wallace, R B (1995). Lowerextremity function in persons over the age of 70 years as a predictor of subsequent disability. The New England Journal of Medicine, 332(9), 556–561. Ferrer E., Salthouse T.A., Stewart W.F., Schwartz B.S. (2004) Modeling age and retest processes in longitudinal studies of cognitive abilities. Psychology and Aging, 19 (2), 243259. Mazzonna F. and Peracchi F. (2009) Aging, cognitive abilities and retirement in Europe. CEIS Tor Vergata Research Paper Series, vol. 7, Issue 5, n. 152. Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012 May;42(5):484-91. Sharp SI, Aarsland D, Day S, Sonnesyn H, Ballard C. Hypertension is a potential risk factor for vascular dementia: systematic review. Int J Geriatr Psychiatry. 2011;26:661–669